TGIWX
Price
$15.47
Change
+$0.15 (+0.98%)
Updated
Jan 17 closing price
Net Assets
6.79B
VFIAX
Price
$553.67
Change
+$5.49 (+1.00%)
Updated
Jan 17 closing price
Net Assets
1.35T
Ad is loading...

TGIWX vs VFIAX

Header iconTGIWX vs VFIAX Comparison
Open Charts TGIWX vs VFIAXBanner chart's image
Nuveen Core Equity W
Price$15.47
Change+$0.15 (+0.98%)
VolumeN/A
Net Assets6.79B
Vanguard 500 Index Admiral
Price$553.67
Change+$5.49 (+1.00%)
VolumeN/A
Net Assets1.35T
TGIWX vs VFIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TGIWX vs. VFIAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TGIWX is a Hold and VFIAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.35T vs. TGIWX (6.79B). TGIWX (1.37) and VFIAX (1.32) have matching dividends . TGIWX was incepted earlier than VFIAX: TGIWX (6 years) vs VFIAX (24 years). TGIWX is a more actively managed with annual turnover of: 108.00 vs. VFIAX (2.00). TGIWX has a lower initial minimum investment than VFIAX: TGIWX (0) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 25.54 vs. TGIWX (19.04). VFIAX return over 5 years is better than : 80.23 vs. TGIWX (7.57).
TGIWXVFIAXTGIWX / VFIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years24 years-
Gain YTD2.7222.010135%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.79B1.35T1%
Annual Yield % from dividends1.371.32104%
Returns for 1 year19.0425.5475%
Returns for 3 years-2.5031.13-8%
Returns for 5 years7.5780.239%
Returns for 10 yearsN/A196.98-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.790.45
+7.10%
LexinFintech Holdings Ltd
GATX154.690.58
+0.38%
GATX Corp
ALC84.370.23
+0.27%
Alcon
ANTX1.27N/A
N/A
AN2 Therapeutics
NMM42.48-1.07
-2.46%
Navios Maritime Partners LP